Mimoza Zaka
Family · Rochester Hills, MINPI 1053786954
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 100 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 15.9% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 100 payments — averaging $96.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acadia Pharmaceuticals Inc$2K
- AstraZeneca$1K
- Teva Pharmaceuticals USA, Inc.$941
- Novo Nordisk$596
- Neurocrine Biosciences, Inc.$588
- Johnson & Johnson$497
- plus $4K from 30 others
What the payments were for
- Food & beverage$9,693100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acadia Pharmaceuticals Inc | 16 | $1,541 |
| AstraZeneca(2 entities) | 13 | $1,487 |
| Teva Pharmaceuticals USA, Inc. | 8 | $941 |
| Novo Nordisk | 5 | $596 |
| Neurocrine Biosciences, Inc. | 6 | $588 |
| Johnson & Johnson(2 entities) | 5 | $497 |
| Otsuka America Pharmaceutical, Inc. | 5 | $497 |
| Medtronic | 2 | $276 |
| Corium, LLC | 10 | $234 |
| Bayer | 2 | $190 |
| Boston Scientific | 3 | $183 |
| Averitas Pharma Inc. | 1 | $145 |
| Inspire Medical Systems, Inc. | 1 | $142 |
| Silk Road Medical, Inc. | 1 | $142 |
| Abiomed | 1 | $139 |
| Agios Pharmaceuticals, Inc. | 1 | $125 |
| Gilead | 1 | $125 |
| Amgen | 1 | $125 |
| Jazz Pharmaceuticals Inc. | 1 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $124 |
| Lilly USA, LLC | 1 | $122 |
| GSK | 1 | $122 |
| Actelion Pharmaceuticals US, Inc. | 1 | $121 |
| Lundbeck LLC | 1 | $115 |
| SK Life Science, Inc. | 1 | $114 |
| Biogen | 1 | $108 |
| Viiv Healthcare Company | 1 | $107 |
| Axsome Therapeutics, Inc. | 1 | $102 |
| Corcept Therapeutics | 1 | $100 |
| Sun Pharmaceutical Industries Inc. | 1 | $95 |
| Eisai Inc. | 1 | $94 |
| Amarin Pharma, Inc. | 1 | $91 |
| Mayne Pharma Commercial LLC | 1 | $80 |
| Coloplast | 1 | $44 |
| Dexcom, Inc. | 1 | $35 |
| Exact Sciences | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NUPLAZID$1,339
- INGREZZA$518
- REXULTI$357
- Wegovy$354
- SOLIRIS$348
- AJOVY$336
- ENROUTE Transcarotid Neuroprotection System$283
- LOKELMA$250
- Austedo XR$246
- AUSTEDO$227
- Qutenza$145
- INTERSTIM$144
- Inspire$142
- ENROUTE Transcarotid Stent$142
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$142
- Impella$139
- UZEDY$132
- SYMPLICITY G3$132
- BREZTRI$127
- ANDEXXA$125
How this compares
$9,693 in reported general payments places this provider in the 95th percentile of 3,657 family providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 52 | $55,311 |
| EliquisApixaban | 96 | $55,062 |
| Invega SustennaPaliperidone Palmitate | 12 | $41,375 |
| JardianceEmpagliflozin | 59 | $35,283 |
| Spiriva RespimatTiotropium Bromide | 35 | $19,411 |
| Atorvastatin Calcium | 341 | $17,881 |
| OzempicSemaglutide | 16 | $16,242 |
| XareltoRivaroxaban | 22 | $11,736 |
| Fluticasone-VilanterolFluticasone/Vilanterol | 22 | $8,463 |
| Quetiapine Fumarate | 75 | $8,297 |
| RhopressaNetarsudil Mesylate | 24 | $8,212 |
| Amlodipine Besylate | 275 | $6,430 |
| Aripiprazole | 16 | $5,874 |
| Tudorza PressairAclidinium Bromide | 12 | $5,686 |
| FarxigaDapagliflozin Propanediol | 11 | $5,535 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Olanzapine | $122 | $59,75587 claims |
| Johnson & JohnsonInvega Sustenna, Xarelto | $497 | $53,11134 claims |
| Novo NordiskOzempic | $596 | $16,24216 claims |
| AstraZenecaFarxiga | $1,487 | $5,53511 claims |
| GSKIncruse Ellipta | $122 | $4,85813 claims |
| Teva Pharmaceuticals USA, Inc.Qvar Redihaler | $941 | $3,63312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,657 family providers in Michigan.
Other family in Rochester Hills
- Jayme HeimGrandville$663K
- Susan WolgamottBloomfield Township$327K
- Elisheva EllenbergDetroit$150K
- Sarah JohnsonFarmington Hills$119K
- Daniela MaximTroy$112K
- Kelsey PrinceGrand Rapids$87K
- Brent MillerFremont$66K
- Rachael CompeauFlint$62K
- David KocendaLapeer$49K
- Tracy RobertsonBay City$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.